Cochlear Ltd (ASX: COH) shares tumbled 4% to $202.02 today despite the hearing aid manufacturer releasing no specific news to the market.
The audiology researcher is due to hand in its financial results for the year ending June 30 2019 on August 16, with analysts expecting a net profit close to $269 million.
The company itself is guiding for a net profit between $265 million to $275 million which would represent growth between 8% to 12% on the prior year.
The stock could be sinking today after the powerful analysts at Goldman Sachs downgraded their rating to a fence sitting “neutral” from “buy” on valuation grounds. The analysts have a $212 12-month share price target on the business, which suggests it has some 5% upside if Goldman’s analysis is on the money.
The analysts are valuing it using a 25.8x forward EV/EBITDA multiple.
5 stocks under $5
We hear it over and over from investors, "I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I'd be sitting on a gold mine!" And it's true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
Tom Richardson owns shares of Cochlear Ltd., CSL Ltd., and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- On a serendipitous day, Tom Richardson is leaving the building – December 17, 2019 11:55am
- Why Aerometrex shares have doubled their IPO price – December 16, 2019 4:32pm
- Why the National Veterinary Care share price is going nuts today – December 16, 2019 3:39pm